Apixaban versus antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation. A randomised phase II clinical trial.
Phase of Trial: Phase II
Latest Information Update: 12 Dec 2018
Price : $35 *
At a glance
- Drugs Apixaban (Primary) ; Aspirin; Carbasalate calcium; Clopidogrel; Dipyridamole
- Indications Stroke; Thromboembolism
- Focus Therapeutic Use
- Acronyms APACHE-AF
- 03 Dec 2018 Planned End Date changed from 1 Sep 2018 to 31 Jan 2021.
- 03 Dec 2018 Planned primary completion date changed from 1 Mar 2018 to 31 Jan 2021.
- 31 Aug 2018 Biomarkers information updated